| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...862757H |
| P356 | DOI | 10.1371/JOURNAL.PONE.0062757 |
| P932 | PMC publication ID | 3653886 |
| P698 | PubMed publication ID | 23690952 |
| P5875 | ResearchGate publication ID | 236925125 |
| P2093 | author name string | Johji Inazawa | |
| Tomoki Muramatsu | |||
| Kiyoshi Harada | |||
| Narikazu Uzawa | |||
| Tatsuyuki Kawano | |||
| Yosuke Harazono | |||
| Hironori Endo | |||
| Ken-ichi Kozaki | |||
| P2860 | cites work | The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 | Q24608778 |
| Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression | Q24633875 | ||
| The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 | Q24646996 | ||
| A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells | Q24649109 | ||
| The microRNA.org resource: targets and expression | Q24650094 | ||
| The epithelial-mesenchymal transition generates cells with properties of stem cells | Q24650786 | ||
| Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells | Q24651034 | ||
| The basics of epithelial-mesenchymal transition | Q24652992 | ||
| Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression | Q24681466 | ||
| Epithelial-mesenchymal transitions in tumour progression | Q27860487 | ||
| The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. | Q42482430 | ||
| MiR-17-92 cluster regulates cell proliferation and collagen synthesis by targeting TGFB pathway in mouse palatal mesenchymal cells. | Q54338492 | ||
| Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients | Q75402919 | ||
| The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer | Q80502357 | ||
| The functions of animal microRNAs | Q27860621 | ||
| Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
| Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
| MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 | ||
| The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 | Q27861068 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer | Q28244254 | ||
| The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs | Q29615910 | ||
| EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer | Q29616360 | ||
| A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition | Q29617690 | ||
| Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. | Q30497690 | ||
| Involvement of members of the cadherin superfamily in cancer | Q33899441 | ||
| MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation | Q34019957 | ||
| Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal cancer cells | Q34090292 | ||
| The Promise of MicroRNA Replacement Therapy | Q34134295 | ||
| An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition | Q34977307 | ||
| Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31. | Q35004231 | ||
| miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma | Q35008738 | ||
| Roles for microRNAs in conferring robustness to biological processes | Q35955737 | ||
| Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells | Q36206995 | ||
| MicroRNAs in biological processes and carcinogenesis. | Q36617667 | ||
| Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers | Q37249141 | ||
| Epithelial-mesenchymal transition in cancer development and its clinical significance | Q37644546 | ||
| Tumor-suppressive microRNA silenced by tumor-specific DNA hypermethylation in cancer cells | Q37982793 | ||
| MicroRNA control of epithelial-mesenchymal transition and metastasis. | Q38017596 | ||
| SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation | Q38328202 | ||
| Lentivirus-delivered ZEB-1 small interfering RNA inhibits lung adenocarcinoma cell growth in vitro and in vivo. | Q39368590 | ||
| MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways. | Q39430328 | ||
| Stabilization of phenotypic plasticity through mesenchymal-specific DNA hypermethylation in cancer cells | Q39483048 | ||
| miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer | Q39484319 | ||
| Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma | Q39732683 | ||
| Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma. | Q39985982 | ||
| Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer | Q39996295 | ||
| Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic hybridization. | Q39996404 | ||
| PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation | Q40114074 | ||
| A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer | Q40235784 | ||
| Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites | Q42419115 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | e62757 | |
| P577 | publication date | 2013-05-14 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2 | |
| P478 | volume | 8 |
| Q38909005 | 14q32-encoded microRNAs mediate an oligometastatic phenotype |
| Q27348866 | A Novel Model of Intravital Platelet Imaging Using CD41-ZsGreen1 Transgenic Rats |
| Q38739519 | Analysis of the correlation between the expression of miR-655 and esophageal cancer prognosis |
| Q49409776 | COX-2 induces oncogenic micro RNA miR655 in human breast cancer. |
| Q57157498 | Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma |
| Q58092284 | Developments in oligometastatic hormone-sensitive prostate cancer |
| Q39108676 | Epigenetics of epithelial-to-mesenchymal transition in pancreatic carcinoma. |
| Q57168604 | Epithelial-mesenchymal transition and microRNAs: Challenges and future perspectives in oral cancer |
| Q47682808 | Establishment of twist-1 and TGFBR2 as direct targets of microRNA-20a in mesenchymal to epithelial transition of breast cancer cell-line MDA-MB-231. |
| Q38727171 | Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma |
| Q47112052 | Functions of pancreatic stellate cell-derived soluble factors in the microenvironment of pancreatic ductal carcinoma |
| Q91935516 | Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis |
| Q37688532 | Induction of epithelial-mesenchymal transition (EMT) by Beclin 1 knockdown via posttranscriptional upregulation of ZEB1 in thyroid cancer cells |
| Q26866533 | Interactions between E-cadherin and microRNA deregulation in head and neck cancers: the potential interplay |
| Q97067035 | Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies |
| Q38248759 | Involvement of epithelial to mesenchymal transition in the development of pancreatic ductal adenocarcinoma |
| Q50650336 | In Vivo Delivery and Therapeutic Effects of a MicroRNA on Colorectal Liver Metastases. |
| Q55086969 | Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway. |
| Q88394552 | LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition |
| Q60920963 | Low levels of tumour suppressor miR-655 in plasma contribute to lymphatic progression and poor outcomes in oesophageal squamous cell carcinoma |
| Q86022545 | Lung metastasis of pancreatic carcinoma is regulated by TGFβ signaling |
| Q33609359 | MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma |
| Q58695821 | MicroRNA Expression Profiles in Gastric Carcinogenesis |
| Q28538690 | MicroRNA-147 induces a mesenchymal-to-epithelial transition (MET) and reverses EGFR inhibitor resistance |
| Q38712795 | MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma |
| Q37697683 | MicroRNA-302d downregulates TGFBR2 expression and promotes hepatocellular carcinoma growth and invasion |
| Q91822425 | MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1 |
| Q29347525 | MicroRNA-590 is an EMT-suppressive microRNA involved in the TGFβ signaling pathway |
| Q36969218 | MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma |
| Q34093798 | MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer |
| Q39166706 | MicroRNAs in esophageal squamous cell carcinoma: Potential biomarkers and therapeutic targets |
| Q26777313 | MicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancer |
| Q88912528 | MicroRNA‑655 inhibits cell proliferation and invasion in epithelial ovarian cancer by directly targeting vascular endothelial growth factor |
| Q33643722 | Mir-655 up-regulation suppresses cell invasion by targeting pituitary tumor-transforming gene-1 in esophageal squamous cell carcinoma |
| Q89148846 | Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application |
| Q40273812 | Norcantharidin modulates miR-655-regulated SENP6 protein translation to suppresses invasion of glioblastoma cells |
| Q38964268 | Overexpression of zinc finger E-box binding homeobox factor 1 promotes tumor invasiveness and confers unfavorable prognosis in esophageal squamous cell carcinoma |
| Q90740955 | Overview on Epigenetic Re-programming: A Potential Therapeutic Intervention in Triple Negative Breast Cancers |
| Q41709626 | PTIP promotes recurrence and metastasis of hepatocellular carcinoma by regulating epithelial-mesenchymal transition |
| Q37681322 | Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions |
| Q58695588 | Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis |
| Q39458257 | Recent progress on the effects of microRNAs and natural products on tumor epithelial-mesenchymal transition. |
| Q49303062 | SNHG16/miR-140-5p axis promotes esophagus cancer cell proliferation, migration and EMT formation through regulating ZEB1. |
| Q35138461 | Temporal analysis of reciprocal miRNA-mRNA expression patterns predicts regulatory networks during differentiation in human skeletal muscle cells |
| Q60923349 | The Role of TGF-β and Its Receptors in Gastrointestinal Cancers |
| Q40689849 | The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis |
| Q38705592 | The role of microRNA in esophageal squamous cell carcinoma |
| Q92253669 | Therapeutic Potential of LNP-Mediated Delivery of miR-634 for Cancer Therapy |
| Q38223512 | Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs |
| Q50063155 | Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer. |
| Q52649778 | miR-106b promotes cell invasion and metastasis via PTEN mediated EMT in ESCC. |
| Q47935656 | miR-218 suppresses epithelial-to-mesenchymal transition by targeting Robo1 and Ecop in lung adenocarcinoma cells |
| Q33822461 | miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer |
| Q35743130 | miR-544a induces epithelial-mesenchymal transition through the activation of WNT signaling pathway in gastric cancer |
| Q36797492 | miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer |
Search more.